Thermo Fisher Scientific at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Thermo Fisher Scientific brings 9 presentations to AMP 2026 in Seattle, and exhibits at Booth 709, MR10, MR4. Its sessions cover precision oncology research, clinical pharmacogenomics and infectious disease workflows, with a strand on alternative sample types beyond tissue. Topics include rapid sequencing that combines pharmacogenomics with genomic profiling in one run, and molecular testing for patients with pancreatic lesions.
| Organization | AMP 2026 Attendance |
|---|---|
Thermo Fisher Scientific Waltham, MA | |
Research and diagnostic solutions for molecular laboratories: next-generation sequencing, real-time PCR, Sanger sequencing and bioinformatics across oncology, pharmacogenomics and infectious disease. | Booth Exhibiting at Booth 709, MR10, MR4 Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm 🏅Silver Partner Workshop Wed, Nov 11 10:00am–10:50am Beyond Tissue: Implementing Alternative Analytes for Molecular Diagnostics in Clinical Practice Using cerebrospinal fluid and fine needle aspirate supernatant for sequencing when tumour tissue is scarce or unavailable. Workshop Wed, Nov 11 11:00am–11:50am Novel NGS Applications in Oncology Research: TCR Sequencing and Methylation-Based ctDNA Analysis T-cell receptor sequencing and methylation-based circulating tumor DNA analysis open new angles on immune response and tumor signals. Workshop Wed, Nov 11 1:00pm–1:50pm Implementing Clinical Pharmacogenomics: Practical Lessons from Assay to Actionable Care Getting pharmacogenomic testing into routine care: test selection, lab workflow, reporting, reimbursement and health record integration. Workshop Wed, Nov 11 2:00pm–2:50pm Advancing precision oncology research: Integrating pharmacogenomics and genomic profiling using a single, rapid NGS workflow on the Genexus System Folding DPYD pharmacogenomic content into tumour sequencing so one run covers both drug-response and tumour profiling. Workshop Wed, Nov 11 3:00pm–3:50pm Bridging the Clinical Gap: Retrospective Microsatellite Instability Testing to Inform Complex Biospecimen Cohort Generation Microsatellite instability testing across hundreds of banked tumor specimens builds characterized cohorts for immunotherapy research. Workshop Wed, Nov 11 8:00am–8:50am The Precision Pathway: How Pathologists Are Transforming Biomarker Discovery, Selection, and Clinical Impact Across GU Cancers Biomarker selection, specimen handling and reporting for genitourinary cancers, worked through interactive case discussions. Workshop Wed, Nov 11 9:00am–9:50am From Assay to Answer: Genomic Technologies and Multiplex Workflow Solutions for Infectious Disease Research Pathogen detection by qPCR and digital PCR, with assay design and multiplexing choices for adding targets within one reaction. Workshop Thu, Nov 12 4:25pm–4:55pm It's Hard to Treat What You Can't See: Leveraging Molecular Diagnostics to Improve Care of Patients with Pancreatic Lesions Pancreatic lesions are hard to call on imaging and cytology alone; molecular testing can sharpen diagnosis and risk stratification. Workshop Thu, Nov 12 6:15pm–6:45pm Unlocking New Possibilities in Myeloid Malignancies MRD Assessment with NGS An NGS assay for measurable residual disease in myeloid cancers, covering its gene content, workflow and reported performance. |
Instantly find 20 buyers from Thermo Fisher Scientific
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction